United States (US) Migraine Drugs Market (2025-2031) | Competitive Landscape, Segmentation, Analysis, Growth, Size & Revenue, Share, Forecast, Companies, Trends, Industry, Outlook, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Migraine Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Migraine Drugs Market - Industry Life Cycle

3.4 United States (US) Migraine Drugs Market - Porter's Five Forces

3.5 United States (US) Migraine Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.6 United States (US) Migraine Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of migraine cases in the US

4.2.2 Rising awareness about migraine treatment options

4.2.3 Technological advancements in migraine drug research and development

4.3 Market Restraints

4.3.1 Stringent regulatory processes for drug approval

4.3.2 Side effects associated with migraine drugs

4.3.3 Competition from alternative therapies such as acupuncture and behavioral therapies

6.1 United States (US) Migraine Drugs Market, By Treatment

6.1.1 Overview and Analysis

6.1.2 United States (US) Migraine Drugs Market Revenues & Volume, By Treatment, 2021- 2031F

6.1.3 United States (US) Migraine Drugs Market Revenues & Volume, By Abortive, 2021- 2031F

6.1.4 United States (US) Migraine Drugs Market Revenues & Volume, By Triptans, 2021- 2031F

6.1.5 United States (US) Migraine Drugs Market Revenues & Volume, By Ergot Alkaloids, 2021- 2031F

6.1.6 United States (US) Migraine Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Migraine Drugs Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 United States (US) Migraine Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 United States (US) Migraine Drugs Market Revenues & Volume, By Injectable, 2021- 2031F

6.2.4 United States (US) Migraine Drugs Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Migraine Drugs Market Export to Major Countries

7.2 United States (US) Migraine Drugs Market Imports from Major Countries

8.1 Patient adherence rate to migraine drug therapy

8.2 Number of clinical trials for new migraine drugs

8.3 Percentage of migraine patients using prescription drugs as a primary treatment option

9.1 United States (US) Migraine Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.2 United States (US) Migraine Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

10.1 United States (US) Migraine Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Migraine Drugs Market Competitive Benchmarking, By Operating and Technical Parameters